Arca Biopharma | ABIO - Les Charges D'Exploitation

Prix De L'Action
60.58
Variation Quotidienne
1.00 1.68%
Mensuellement
76.05%
Annuel
688.80%
Q2 Prévisions
57.95




Les Charges D'Exploitation Changement Date
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Amgen USD 5.9B 773M 2025-12
Arca Biopharma USD 34.43M 326K 2025-12
Biogen USD 1.88B 81.4M 2025-09
Brainstorm Cell Therapeutics USD 2.24M 197K 2025-12
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Capricor Therapeutics USD 29.16M 2.87M 2025-12
Cipla INR 60.98B 1.06B 2025-12
Clal Biotechnology ILS 5.15M 9.47M 2022-12
Compugen USD 11.29M 1.51M 2025-12
CSL USD 5.7B 2.82B 2025-12
Cytokinetics USD 196.12M 27.43M 2025-12
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Grifols EUR 1.99B 217.4M 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
Otsuka Holdings JPY 582.9B 113.74B 2025-12
Pfizer USD 12.91B 79.89B 2025-12
United Therapeutics USD 804.8M 5.79B 2025-12